169 related articles for article (PubMed ID: 21316126)
1. [Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].
Becerra Bachino V; Cots F; Guedea F; Pera J; Boladeras A; Aguiló F; Suárez JF; Gallo P; Murgui L; Pont A; Cunillera O; Pardo Y; Ferrer M;
Gac Sanit; 2011; 25(1):35-43. PubMed ID: 21316126
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
4. Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
[TBL] [Abstract][Full Text] [Related]
5. Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience.
Satoh T; Ishiyama H; Matsumoto K; Tabata K; Kitano M; Iwamura M; Kimura M; Minamida S; Yamashita H; Matsuda D; Kotani S; Niibe Y; Uemae M; Hayakawa K; Baba S
Jpn J Radiol; 2009 Nov; 27(9):348-54. PubMed ID: 19943145
[TBL] [Abstract][Full Text] [Related]
6. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer.
Burkhardt JH; Litwin MS; Rose CM; Correa RJ; Sunshine JH; Hogan C; Hayman JA
J Clin Oncol; 2002 Jun; 20(12):2869-75. PubMed ID: 12065564
[TBL] [Abstract][Full Text] [Related]
7. Perioperative costs and charges of prostate brachytherapy and prostatectomy.
Makhlouf AA; Boyd JC; Chapman TN; Theodorescu D
Urology; 2002 Oct; 60(4):656-60. PubMed ID: 12385928
[TBL] [Abstract][Full Text] [Related]
8. Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.
Norderhaug I; Dahl O; Høisaeter PA; Heikkilä R; Klepp O; Olsen DR; Kristiansen IS; Waehre H; Bjerklund Johansen TE
Eur Urol; 2003 Jul; 44(1):40-6. PubMed ID: 12814673
[TBL] [Abstract][Full Text] [Related]
9. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
10. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
11. [Valorisation of brachytherapy and medico-economic considerations].
Pommier P; Morelle M; Millet-Lagarde F; Peiffert D; Gomez F; Perrier L
Cancer Radiother; 2013 Apr; 17(2):178-81. PubMed ID: 23601252
[TBL] [Abstract][Full Text] [Related]
12. The perioperative charge equivalence of interstitial brachytherapy and radical prostatectomy with 1-year followup.
Kohan AD; Armenakas NA; Fracchia JA
J Urol; 2000 Feb; 163(2):511-4. PubMed ID: 10647667
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract][Full Text] [Related]
14. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
15. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
16. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
Kibel AS; Ciezki JP; Klein EA; Reddy CA; Lubahn JD; Haslag-Minoff J; Deasy JO; Michalski JM; Kallogjeri D; Piccirillo JF; Rabah DM; Yu C; Kattan MW; Stephenson AJ
J Urol; 2012 Apr; 187(4):1259-65. PubMed ID: 22335870
[TBL] [Abstract][Full Text] [Related]
17. Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.
Maguire PD; Waterman FM; Dicker AP
Tech Urol; 2000 Jun; 6(2):85-8. PubMed ID: 10798805
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
Forsythe K; Blacksburg S; Stone N; Stock RG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
[TBL] [Abstract][Full Text] [Related]
19. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.
Polascik TJ; Pound CR; DeWeese TL; Walsh PC
Urology; 1998 Jun; 51(6):884-9; discussion 889-90. PubMed ID: 9609622
[TBL] [Abstract][Full Text] [Related]
20. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
Brandeis J; Pashos CL; Henning JM; Litwin MS
Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]